However, the observed was in the same direction as all other analyses, yet it did not reach statistical significance (ie, supporting once-daily UMEC/VI over twice-daily ICS/LABA; p=0.1294) ( Supplementary Table 2 ).
← all excerpts
Comparative Effectiveness of Umeclidinium/Vilanterol versus Inhaled Corticosteroid/Long-Acting β<sub>2</sub>-Agonist in Patients with Chronic Obstructive Pulmonary Disease in a Primary Care Setting in England.
1
0.1294
0.1294